(Q40398453)

20 September 2017

1 reference

title

Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis (English)

1 reference

20 September 2017

0 references

H M Bryson

1

1 reference

PubMed ID

7533697

20 September 2017

E M Sorkin

series ordinal

2

1 reference

20 September 2017

1 December 1994

1 reference

20 September 2017

1 reference

20 September 2017

48

1 reference

20 September 2017

6

1 reference

20 September 2017

894-906

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199448060-00006

20 September 2017

0 references

cites work

Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein

1 reference

12 December 2020

Identification of the cystic fibrosis gene: chromosome walking and jumping

1 reference

12 December 2020

1 reference

12 December 2020

Consensus conference: practical applications of Pulmozyme. September 22, 1993.

1 reference

12 December 2020

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

12 December 2020

Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

1 reference

12 December 2020

Pancreatic dornase aerosols in bronchopulmonary disease

1 reference

12 December 2020

Drug Therapy in the 1990s : What Can We Expect for Cystic Fibrosis?

1 reference

12 December 2020

Evolution of therapy for cystic fibrosis

1 reference

12 December 2020

Inhibition of protease activity in purulent sputum by DNA

1 reference

12 December 2020

Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

1 reference

12 December 2020

Pus, deoxyribonucleic acid, and sputum viscosity

1 reference

12 December 2020

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

1 reference

12 December 2020

Antibiotic activity in sputum

1 reference

12 December 2020

Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum

1 reference

12 December 2020

1 reference

12 December 2020

Bronchospasm after inhalation of pancreatic dornase

1 reference

12 December 2020

Cystic fibrosis: molecular biology and therapeutic implications

1 reference

12 December 2020

Biochemical and molecular genetics of cystic fibrosis

1 reference

12 December 2020

New treatments for cystic fibrosis

1 reference

12 December 2020

Lobar atelectasis in cystic fibrosis and treatment with recombinant human DNase I

1 reference

12 December 2020

The appropriate use of mucolytic agents

1 reference

12 December 2020

Identification of the cystic fibrosis gene: genetic analysis

1 reference

12 December 2020

[Pulmozyme (Dornase alfa)]

1 reference

12 December 2020

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

12 December 2020

Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom

1 reference

12 December 2020

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

12 December 2020

The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

1 reference

12 December 2020

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

1 reference

12 December 2020

Pharmaco-toxicological expert report Pulmozyme rhDNase Genentech, Inc.

1 reference

12 December 2020

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

12 December 2020

The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum

1 reference

12 December 2020

The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases

1 reference

12 December 2020

10.2165/00003495-199448060-00006

Identifiers

DOI

1 reference

PubMed ID

7533697

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

7533697